Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107028 · ClinicalTrials.gov registry record
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 41
- Enrollment target
NCT01107028: Completed study, sponsored by National Jewish Health.
NCT01107028 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01107028 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might improve them. The hypotheses of this particular study are that pulmonary rehabilitation (PR) is one such intervention, and that PR will improve the sequelae of dyspnea and impairments in functional capacity, cognition, mood and anxiety, fatigue, and quality of life (QOL) in patients with IPF.
Primary Outcome
Distance walked during a standard six-minute walk test.
Interventions
- OTHER Standard pulmonary rehabilitation program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-10 |
What the finished NCT01107028 record still lists
NCT01107028 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Standard pulmonary rehabilitation program is the first listed.
NCT01107028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01107028 about?
NCT01107028 is a clinical study titled "Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis". Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might i...
What is the current status of trial NCT01107028?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2010-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01107028?
The interventions under investigation include: Standard pulmonary rehabilitation program (OTHER).
Who is sponsoring clinical trial NCT01107028?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia